CIRCULATING MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (MIP1-A) AS A POTENTIAL BIOMARKER FOR THE DIAGNOSIS OF PATIENTS WITH PANCREATIC ADENOCARCINOMA

Karabulut S., Afsar C. U., Karabulut M., Alis H., Binboga S., Ozkara I. O., ...Daha Fazla

ACTA MEDICA MEDITERRANEA, cilt.32, sa.4, ss.1035-1040, 2016 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 4
  • Basım Tarihi: 2016
  • Doi Numarası: 10.19193/0393-6384_2016_4_128
  • Dergi Adı: ACTA MEDICA MEDITERRANEA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1035-1040
  • İstanbul Üniversitesi Adresli: Evet

Özet

Introduction: Pancreatic cancer is the fourth leading cause of cancer-related death in the United States among both men and women. Macrophage inflammatory protein-1 alpha [MIP-1 alpha/CC-chemokine ligand 3 (CCL3)] is a small chemotactic protein detected in several kinds of tumor tissue samples and functions as a key regulator of cancer progression. This study aimed to investigate the serum MIP-1 alpha/CCL3 levels in pacreatic adenocarcinoma (PA).